Research Progress on the Application of Remimazolam as a Novel Sedative-Anesthetic Agent

Read full text Summarise with VIRAT
Authors: Ziqing Zhu, Aidong Li, Yukang Gong, Baichi Chen, Qian Li
Cited by: 0
References: 15

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Remimazolam is a novel, ultra-short-acting benzodiazepine characterized by its rapid onset of action. It has been approved for procedural sedation and general anesthesia, exhibiting typical pharmacodynamic profiles akin to other benzodiazepines, such as midazolam. The drug demonstrates high organ-independent clearance and acts primarily on the γ-aminobutyric acid type A (GABA-A) receptors. It is rapidly metabolized by nonspecific esterases, predominantly carboxylesterases, into inactive metabolites with significantly reduced binding affinity—approximately 300 to 400 times lower for GABA-A receptors compared to the parent compound. Following administration, plasma concentrations of remimazolam decline predictably and rapidly; at adequate doses, no prolonged sedative effects are observed. Currently, remimazolam has been successfully employed in endoscopic procedures as well as for the induction and maintenance of general anesthesia, offering rapid and predictable onset and recovery, minimal impact on respiratory and hemodynamic parameters, and an absence of severe drug-related adverse events. Moreover, its effects can be reversed by flumazenil. Although remimazolam holds considerable potential for sedation in patients requiring anesthesia, further research is needed to evaluate its efficacy and safety in broader sedative applications. This review aims to outline the pharmacokinetic profile of remimazolam, its current clinical utility, and future directions in clinical practice.

Fields of Study & Subjects

Anesthesia and Sedative Agents Veterinary Pharmacology and Anesthesia Anesthesia and Pain Management

Publication details

Journal / source
International Journal of Biology and Life Sciences
Volume
13
Issue
3
Pages
124–127
Publication date
23 March 2026
Language
EN